BackAlbany Molecular Research Overview

Albany Molecular Research Net Tangible Assets

Albany Molecular Research's net tangible assets is $320M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$317.02M
20.57% YoYΔ $54.09M vs prior year quarter

Peer trimmed avg / median

Loading

Albany Molecular Research Net Tangible Assets History

Loading

Albany Molecular Research vs. peers: Net Tangible Assets Comparison

Loading

Albany Molecular Research Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Albany Molecular Research (AMRI) FAQ

As of the most recent data (June 2017), AMRI shows a net tangible assets of $320M. That compares with $260M in the prior-year period — up 20.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMRI's net tangible assets is now $320M (was $260M) — a 20.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Albany Molecular Research is outperforming or lagging.

Tracking AMRI's net tangible assets over time shows whether Albany Molecular Research is scaling, shrinking, or reshaping that part of the business. The current reading is $320M That compares with $260M in the prior-year period — up 20.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Albany Molecular Research's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $320M) with ownership activity and broader fundamentals.